Lymphopenia during chemoradiation—foe or friend

BACKGROUND: Severe lymphopenia during treatment is considered to be a poor prognostic factor. The current literature lacks information regarding its impact on various outcomes in locally advanced head-and-neck cancer patients in a prospective setting. METHODS: We recently published a randomised stud...

詳細記述

保存先:
書誌詳細
出版年:Ecancermedicalscience
主要な著者: Patil, Vijay M, Singh, Gunjesh Kumar, Noronha, Vanita, Joshi, Amit, Menon, Nandini, Lashkar, Sarbani Ghosh, Mathrudev, Vijayalakshmi, Satam, Kavita Nawale, Mukadam, Sadaf Abdulazeez, Prabhash, Kumar
フォーマット: Artigo
言語:Inglês
出版事項: Cancer Intelligence 2020
主題:
Short Communication
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7581337/
https://ncbi.nlm.nih.gov/pubmed/33144877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2020.1109
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料